Cuneo A, Foà R. RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?. Mediterr J Hematol Infect Dis [Internet]. 2019 Feb. 27 [cited 2024 Nov. 25];11(1):e2019024. Available from: https://www.mjhid.org/mjhid/article/view/2019.024